Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region ForumsAmneal running out of hydroxychloroquine raw material due to Finnish restrictions
Source: Reuters
BIG STORY 12 APRIL 10, 2020 / 11:20 AM / UPDATED 10 MINUTES AGO
Exclusive: Amneal running out of hydroxychloroquine raw material due to Finnish restrictions
Michael Erman, Anne Kauranen
4 MIN READ
NEW YORK/HELSINKI (Reuters) - Amneal Pharmaceuticals could soon run out of the raw ingredients to make more of the antimalarial drug hydroxychloroquine that has been touted as a potential treatment for COVID-19 because Finland is keeping the drug for domestic use, according to the generic drugmakers chief executives.
Amneal has committed to producing about 20 million hydroxychloroquine tablets by mid-April, but will face challenges making any more after that because of difficulties acquiring active pharmaceutical ingredients from its supplier in Finland, co-CEOs Chirag and Chintu Patel said in an interview.
As the demand has increased all across the globe... the Finnish government has put out an emergency order to prioritize their domestic use for local needs, co-CEO Chintu Patel said in an interview on Tuesday.
Hydroxychloroquine is a decades-old drug promoted by many, including U.S. President Donald Trump, as a potential weapon against COVID-19. It has become a standard of care in areas of the United States hit hard by the pandemic, even though doctors prescribing it have no idea whether it works.
Demand for the drug has soared worldwide and some countries, like India, have placed restrictions on its export. Amneal currently manufactures hydroxychloroquine in India and the brothers said the company was working with India to provide an exception to ship its finished product to the U.S.
-snip-
Exclusive: Amneal running out of hydroxychloroquine raw material due to Finnish restrictions
Michael Erman, Anne Kauranen
4 MIN READ
NEW YORK/HELSINKI (Reuters) - Amneal Pharmaceuticals could soon run out of the raw ingredients to make more of the antimalarial drug hydroxychloroquine that has been touted as a potential treatment for COVID-19 because Finland is keeping the drug for domestic use, according to the generic drugmakers chief executives.
Amneal has committed to producing about 20 million hydroxychloroquine tablets by mid-April, but will face challenges making any more after that because of difficulties acquiring active pharmaceutical ingredients from its supplier in Finland, co-CEOs Chirag and Chintu Patel said in an interview.
As the demand has increased all across the globe... the Finnish government has put out an emergency order to prioritize their domestic use for local needs, co-CEO Chintu Patel said in an interview on Tuesday.
Hydroxychloroquine is a decades-old drug promoted by many, including U.S. President Donald Trump, as a potential weapon against COVID-19. It has become a standard of care in areas of the United States hit hard by the pandemic, even though doctors prescribing it have no idea whether it works.
Demand for the drug has soared worldwide and some countries, like India, have placed restrictions on its export. Amneal currently manufactures hydroxychloroquine in India and the brothers said the company was working with India to provide an exception to ship its finished product to the U.S.
-snip-
Read more: https://www.reuters.com/article/us-health-coronavirus-amneal-exclusive/exclusive-amneal-running-out-of-hydroxychloroquine-raw-material-due-to-finnish-restrictions-idUSKCN21S1LE
InfoView thread info, including edit history
TrashPut this thread in your Trash Can (My DU » Trash Can)
BookmarkAdd this thread to your Bookmarks (My DU » Bookmarks)
4 replies, 520 views
ShareGet links to this post and/or share on social media
AlertAlert this post for a rule violation
PowersThere are no powers you can use on this post
EditCannot edit other people's posts
ReplyReply to this post
EditCannot edit other people's posts
Rec (4)
ReplyReply to this post
4 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
Amneal running out of hydroxychloroquine raw material due to Finnish restrictions (Original Post)
Eugene
Apr 2020
OP
gordianot
(15,234 posts)1. As planned.
jberryhill
(62,444 posts)3. There is zero reliable evidence it is of any therapeutic value
Numerous places that were testing it have discontinued its use.
ananda
(28,837 posts)4. And lots of evidence that it has very dangerous effects ..
.. on many who have heart trouble or other underlying
health conditions.
at140
(6,110 posts)2. India has 12 times density of population as United States and 4 times as many people
Yet their death rate from covid-19 is minuscule in comparison. The 600 million cell phone owners in India would not be quiet if people were dying en masse.